1. DA‐EPOCH‐R VERSUS R‐CHOP IN HIGH RISK DLBCL PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP (CLSG). (12th June 2019) Authors: Šimkovič, M.; Móciková, H.; Ďuraš, J.; Kamarádová, K.; Štěpánková, P.; Janíková, A.; Michalka, J.; Žák, P.; Belada, D.; Trněný, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FIRST‐LINE ADJUVANT RADIOTHERAPY IMPROVES PFS IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA ‐ A RETROSPECTIVE ANALYSIS OF 102 PATIENTS FROM A SINGLE CENTER. (12th June 2019) Authors: Salek, D.; Janikova, A.; Michalka, J.; Miculkova, E.; Hadrabova, M.; Folber, F.; Kral, Z.; Mayer, J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRONTLINE THERAPY RESULTS IN UNSELECTED PRIMARY CNS LYMPHOMA PATIENTS WITHOUT CONSOLIDATION HD CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION. (12th June 2019) Authors: Michalka, J.; Salek, D.; Miculkova, E.; Hadrabova, M.; Janikova, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PROGNOSTIC VALUE OF THE INTERVAL BETWEEN RELAPSE AND THERAPY INITIATION IN DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS. ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP DATABASE. (12th June 2019) Authors: Janikova, A.; Chloupkova, R.; Campr, V.; Kopalova, N.; Klener, P.; Benesova, K.; Hamouzova, J.; Belada, D.; Sykorova, A.; Prochazka, V.; Pirnos, J.; Duras, J.; Mocikova, H.; Michalka, J.; Trneny, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗